Auspex Pharmaceuticals Inc, Teva deal

Teva will acquire neurology play Auspex for $101 per share in cash, or about $3.5 billion. The price is a 42% premium to Auspex’s close of $70.91 on March 27, the last trading day before the deal was announced. The deal is slated to close mid-year. ...